| Severe obesity among patients with left ventricular assist devices CK Medina, SG Barnes, GM Felker, RJ Mentz, NJ Pagidipati, KA Seymour, ... American Heart Journal 274, 130-133, 2024 | | 2024 |
| Decongestion Strategies for Ambulatory Outpatients: The Proof Is in the Urine P Rambarat, GM Felker Heart Failure, 2024 | | 2024 |
| Distinct comorbidity clusters in patients with acute heart failure: data from RELAX-AHF-2 KA Gomez, J Tromp, SM Figarska, IE Beldhuis, G Cotter, BA Davison, ... JACC: Heart Failure, 2024 | | 2024 |
| Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study GM Felker, SD Solomon, M Metra, JJV Mcmurray, R Diaz, B Claggett, ... Journal of cardiac failure 30 (6), 755-763, 2024 | | 2024 |
| Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID‐19 infection: The PARACOR‐19 randomized clinical trial SJ Greene, RK Chambers, JB Lerman, J Harrington, CR deFilippi, ... European Journal of Heart Failure, 2024 | | 2024 |
| Utilizing Quality of Life Adjusted Days Alive and Out of Hospital in Heart Failure Clinical Trials P Gouda, S Rathwell, E Colin-Ramirez, GM Felker, H Ross, J Escobedo, ... Circulation: Cardiovascular Quality and Outcomes 17 (5), e010560, 2024 | | 2024 |
| Isovolumic Contraction Velocity In Heart Failure With Reduced Ejection Fraction And Effect Of Sacubitril/valsartan: The PROVE-HF Study AMS Omar, S Murphy, GM Felker, I Piña, J Butler, Y Liu, R Mohebi, ... Journal of Cardiac Failure 30 (5), 653-665, 2024 | 1 | 2024 |
| Putting more weight on obesity trials in heart failure J Harrington, N Sattar, GM Felker, JL Januzzi, CSP Lam, NJ Pagidipati, ... Current heart failure reports, 1-9, 2024 | 1 | 2024 |
| Remote Follow-up in a Heart Failure Pragmatic Trial: Insights From the CONNECT-HF S Shoji, LA Kaltenbach, BB Granger, GC Fonarow, HR Al-Khalidi, ... Journal of Cardiac Failure, 2024 | | 2024 |
| RECOVER-ENERGIZE: A Platform Protocol for Evaluation of Interventions for Exercise Intolerance in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) GM Felker, B Make, L Bateman, J Friedly | | 2024 |
| Worth Their Weight? An Update on New and Emerging Pharmacologic Agents for Obesity and Their Potential Role for Persons with Cardiac Conditions J Harrington, GM Felker, JL Januzzi, CSP Lam, I Lingvay, NJ Pagidipati, ... Current Cardiology Reports 26 (3), 61-71, 2024 | | 2024 |
| Tricuspid regurgitation and clinical outcomes in heart failure with reduced ejection fraction M Adamo, M Metra, BL Claggett, ZM Miao, R Diaz, GM Felker, ... Heart Failure 12 (3), 552-563, 2024 | 3 | 2024 |
| Prognostic impact of repeated NT-proBNP measurements in patients with heart failure with reduced ejection fraction MA Fuery, ES Leifer, MD Samsky, S Sen, CM O’Connor, M Fiuzat, ... Heart Failure 12 (3), 479-487, 2024 | 2 | 2024 |
| Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping MG Dimond, NE Ibrahim, M Fiuzat, JJV McMurray, JA Lindenfeld, ... Heart Failure 12 (3), 451-460, 2024 | 4 | 2024 |
| Reply to ‘Vasodilators in congestive heart failure: The perfect weapon aiming just off the target?’ P Pellicori, GM Felker, JGF Cleland European Journal of Heart Failure 26 (2), 528-528, 2024 | | 2024 |
| Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial RL Rothman, TG Stewart, A Mourad, D Boulware, MW McCarthy, ... medRxiv, 2024.05. 16.24307115, 2024 | | 2024 |
| Implications of trial eligibility in patients with heart failure with mildly reduced or preserved ejection fraction AE Peters, RM Clare, K Chiswell, J Harrington, A Kelsey, A Hernandez, ... ESC Heart Failure, 2024 | 1 | 2024 |
| Natriuresis-Guided Titration of Loop Diuretics in Heart Failure: Another Brick in the Wall GM Felker Circulation: Heart Failure 17 (1), e011359, 2024 | | 2024 |
| Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper A Lala, CE Hamo, B Bozkurt, M Fiuzat, V Blumer, D Bukhoff, J Butler, ... Heart Failure 12 (1), 1-15, 2024 | 1 | 2024 |
| Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS‐986231) P Pellicori, JGF Cleland, M Borentain, J Taubel, FJ Graham, J Khan, ... European Journal of Heart Failure 26 (1), 142-151, 2024 | 5 | 2024 |
CM O'ConnorVerified email at inova.org